In danger: HIV vaccine research and development in Europe
Year: 2025
Type: article
Abstract: Highly effective antiretroviral-based HIV prevention plays an important role in ending the global HIV/AIDS epidemic. However, the sustainable control of the epidemic is hampered by unequal access to prevention options, including HIV testing, alongside with drug resistance and ongoing barriers to accessing sustainable HIV treatment. Therefore, an HIV vaccine, combined with effective prevention and treatment, remains an absolute necessity to control the epidemic. Yet, the recent discontinuation of four major vaccine efficacy studies is raising concerns about the future of HIV vaccine research and development globally, and particularly in the European region where funding for vaccine research and development has shrinked. This viewpoint emphasises that supporting HIV vaccine research and development at the European level remains crucial: it is not only necessary to control the epidemic, but it promotes innovation, strengthens health security, epidemic preparedness, and health sovereignty while contributing to the economies of European nations.
DOI: 10.5167/uzh-283224
Authors: TATOUD, Roger, Lévy, Yves, Le Grand, Roger, Alcami, Jose, Barbareschi, Giorgio, Brander, Christian, Cara, Andrea, Combadière, Behazine, DABIS, FRANCOIS, Fidler, Sarah, Hanke, Tomas, Herrera, Carolina, Karlsson Hedestam, Gunilla, Kuipers, Hester, McCormack, Sheena, MOOG, Christiane, Pantaleo, Giuseppe, Richert, Laura, Sanders, Rogier W, Shattock, Robin, Streeck, Hendrik, Thiebaut, Rodolphe, Trkola, Alexandra, Ueberla, Klaus, Van Gils, Marit J., Wagner, Ralf, Weissenhorn, Winfried, Yazdanpanah, Yazdan, Scarlatti, Gabriella, Lelievre, Jean-Daniel
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7126015832